Q2 2023 Earnings Estimate for Harrow Health, Inc. Issued By B. Riley (NASDAQ:HROW)

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley lifted their Q2 2023 earnings estimates for shares of Harrow Health in a note issued to investors on Thursday, July 20th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.00 per share for the quarter, up from their […]

Related Keywords

Alger ,Algeria , ,Eton Pharmaceuticals Inc ,Harrow Health Price Performance ,Pharmaceuticals Inc ,Harrow Health Company Profile ,Surface Ophthalmics Inc ,News Ratings For Harrow Health Daily ,Fred Alger Management ,Squarepoint Ops ,Steward Partners Investment Advisory ,Harrow Health Inc ,Nasdaq ,Harrow Health ,Free Report ,Get Free Report ,Lake Street Capital ,Street Corp ,Partners Investment Advisory ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Harrow Health Daily ,Nasdaq Hrow ,Throw ,Medical ,Earnings Estimates ,B Riley ,